- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05788250
RC Repair Versus Subacromial Balloon Spacer in Older Adults
April 1, 2024 updated by: Panam Clinic
Randomized Clinical Trial Comparing Rotator Cuff Repair (RCR) With Subacromial Balloon Spacer (SBS) Implantation
The purpose of this pilot study is to assess the feasibility of a full randomized trial design.
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Detailed Description
The feasibility objectives are:
Recruitment
- To establish an estimate of the proportion of patients screened who are eligible for inclusion, and of those, the proportion who consent.
- To establish an estimate of the proportion of eligible patients with medium/large tears versus massive tears.
- Surgery -to confirm agreement among surgeons regarding the protocol's standardized surgical techniques of both groups.
Clinical objectives for observational purposes only are as follows:
- Patient reported and clinical outcomes.
- Number of "failures" in each group (defined as additional surgery and/or having <12% improvement in SANE score from baseline).
Study Type
Interventional
Enrollment (Estimated)
32
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Brenna Cyr, BKin
- Phone Number: 204-927-2828
- Email: bcyr@panamclinic.com
Study Contact Backup
- Name: Sheila McRae, PhD
- Phone Number: 204-925-7469
- Email: smcrae@panamclinic.com
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
70 years and older (Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- 70 years of age or older
- clinical and radiological diagnosis of a full thickness supraspinatus (or larger) RC tear >2cm or more than 1 full tendon
- ongoing symptoms after 3 months of physiotherapy
- a tendon amenable to partial or complete repair (as determined by pre-operative MRI)
- absence glenohumeral arthritis (Hamada < 3)
- absence of neoplastic diseases at treated site
Exclusion Criteria:
- previous surgery or pseudoparalysis on study shoulder
- complete subscapularis deficiency
- external rotation lag signs
- avascular necrosis
- post-infectious arthritis
- proximal humerus fracture
- inflammatory arithritis
- axillary nerve palsy
- concomitant tendon transfer
- neuromuscular disorder
- unable to speak/read English
Intra-operative Exclusion:
-tendon is NOT amenable to partial or complete repair
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Subacromial spacer implantation
|
A biodegradable balloon implanted arthroscopically between the acromion and humeral head with tenotomy of long head of biceps.
|
|
Active Comparator: Rotator Cuff Repair
|
Rotator cuff repair with tenotomy of long head of biceps.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Study feasibility - randomized
Time Frame: 1 year
|
Percentage of patients randomized
|
1 year
|
|
Study feasibility - recruitment
Time Frame: 1 year
|
Number of screened patients and proportion that are deemed eligible that consent
|
1 year
|
|
Study feasibility - surgery
Time Frame: 1 year
|
Consensus among surgeon co-investigators regarding the standardized peri-operative orders and surgical techniques.
|
1 year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
ASES Score
Time Frame: Baseline, pre-operative
|
The ASES is a patient-reported upper extremity-specific functional assessment tool and is scored out of a maximum 100 points, where 100 represents maximum function and no pain (Richards et al., 1994).
It has a pain component measured on a visual analog scale as well as ten Likert-scale questions on function (e.g., put on a coat, sleep on affected side).
The ASES is reliable and is validated for this population and is one of the most commonly used shoulder outcomes in North America.
|
Baseline, pre-operative
|
|
ASES Score
Time Frame: 3 Months, post-operative
|
The ASES is a patient-reported upper extremity-specific functional assessment tool and is scored out of a maximum 100 points, where 100 represents maximum function and no pain (Richards et al., 1994).
It has a pain component measured on a visual analog scale as well as ten Likert-scale questions on function (e.g., put on a coat, sleep on affected side).
The ASES is reliable and is validated for this population and is one of the most commonly used shoulder outcomes in North America
|
3 Months, post-operative
|
|
ASES Score
Time Frame: 6 Months, post-operative
|
The ASES is a patient-reported upper extremity-specific functional assessment tool and is scored out of a maximum 100 points, where 100 represents maximum function and no pain (Richards et al., 1994).
It has a pain component measured on a visual analog scale as well as ten Likert-scale questions on function (e.g., put on a coat, sleep on affected side).
The ASES is reliable and is validated for this population and is one of the most commonly used shoulder outcomes in North America
|
6 Months, post-operative
|
|
ASES Score
Time Frame: 12 Months, post-operative
|
The ASES is a patient-reported upper extremity-specific functional assessment tool and is scored out of a maximum 100 points, where 100 represents maximum function and no pain (Richards et al., 1994).
It has a pain component measured on a visual analog scale as well as ten Likert-scale questions on function (e.g., put on a coat, sleep on affected side).
The ASES is reliable and is validated for this population and is one of the most commonly used shoulder outcomes in North America
|
12 Months, post-operative
|
|
ASES Score
Time Frame: 24 Months, post-operative
|
The ASES is a patient-reported upper extremity-specific functional assessment tool and is scored out of a maximum 100 points, where 100 represents maximum function and no pain (Richards et al., 1994).
It has a pain component measured on a visual analog scale as well as ten Likert-scale questions on function (e.g., put on a coat, sleep on affected side).
The ASES is reliable and is validated for this population and is one of the most commonly used shoulder outcomes in North America
|
24 Months, post-operative
|
|
EQ5D-3L
Time Frame: Baseline, pre-operative
|
The EQ-5D is valid, reliable, responsive PROM used to document overall wellness based on 5 dimensions: mobility, self-care, usual activities, pain, anxiety/depression (Herdman et al., 2011).
A single value is calculated (the value index), which indicates how good or bad a patient's health state is relative to a specified population.
There are two components, VAS for general health, with 0 minimum and 100 maximum, with higher scores being more positive.
The second component is a 25 point scale with minimum 5 and maximum 25 wit h lower scores more positive.
|
Baseline, pre-operative
|
|
EQ5D-3L
Time Frame: 3 Months, post-operative
|
The EQ-5D is valid, reliable, responsive PROM used to document overall wellness based on 5 dimensions: mobility, self-care, usual activities, pain, anxiety/depression (Herdman et al., 2011).
A single value is calculated (the value index), which indicates how good or bad a patient's health state is relative to a specified population.
There are two components, VAS for general health, with 0 minimum and 100 maximum, with higher scores being more positive.
The second component is a 25 point scale with minimum 5 and maximum 25 wit h lower scores more positive.
|
3 Months, post-operative
|
|
EQ5D-3L
Time Frame: 6 Months, post-operative
|
The EQ-5D is valid, reliable, responsive PROM used to document overall wellness based on 5 dimensions: mobility, self-care, usual activities, pain, anxiety/depression (Herdman et al., 2011).
A single value is calculated (the value index), which indicates how good or bad a patient's health state is relative to a specified population.
There are two components, VAS for general health, with 0 minimum and 100 maximum, with higher scores being more positive.
The second component is a 25 point scale with minimum 5 and maximum 25 wit h lower scores more positive.
|
6 Months, post-operative
|
|
EQ5D-3L
Time Frame: 12 Months, post-operative
|
The EQ-5D is valid, reliable, responsive PROM used to document overall wellness based on 5 dimensions: mobility, self-care, usual activities, pain, anxiety/depression (Herdman et al., 2011).
A single value is calculated (the value index), which indicates how good or bad a patient's health state is relative to a specified population.
There are two components, VAS for general health, with 0 minimum and 100 maximum, with higher scores being more positive.
The second component is a 25 point scale with minimum 5 and maximum 25 wit h lower scores more positive.
|
12 Months, post-operative
|
|
EQ5D-3L
Time Frame: 24 Months, post-operative
|
The EQ-5D is valid, reliable, responsive PROM used to document overall wellness based on 5 dimensions: mobility, self-care, usual activities, pain, anxiety/depression (Herdman et al., 2011).
A single value is calculated (the value index), which indicates how good or bad a patient's health state is relative to a specified population.
There are two components, VAS for general health, with 0 minimum and 100 maximum, with higher scores being more positive.
The second component is a 25 point scale with minimum 5 and maximum 25 wit h lower scores more positive.
|
24 Months, post-operative
|
|
SANE Score
Time Frame: Baseline, pre-operative
|
The Single Assessment Numeric Evaluation (SANE) score is a single question that asks patients to rate their affected shoulder as a percentage of normal to provide a simple and efficient measure of patient outcome (Gowd et al., 2019).
Patients will be asked the following question: "How would you rate your affected shoulder today as a percentage of normal (0% to 100% scale with 100% being normal)?"
|
Baseline, pre-operative
|
|
SANE Score
Time Frame: 3 Months, post-operative
|
The Single Assessment Numeric Evaluation (SANE) score is a single question that asks patients to rate their affected shoulder as a percentage of normal to provide a simple and efficient measure of patient outcome (Gowd et al., 2019).
Patients will be asked the following question: "How would you rate your affected shoulder today as a percentage of normal (0% to 100% scale with 100% being normal)?"
|
3 Months, post-operative
|
|
SANE Score
Time Frame: 6 Months, post-operative
|
The Single Assessment Numeric Evaluation (SANE) score is a single question that asks patients to rate their affected shoulder as a percentage of normal to provide a simple and efficient measure of patient outcome (Gowd et al., 2019).
Patients will be asked the following question: "How would you rate your affected shoulder today as a percentage of normal (0% to 100% scale with 100% being normal)?"
|
6 Months, post-operative
|
|
SANE Score
Time Frame: 12 Months, post-operative
|
The Single Assessment Numeric Evaluation (SANE) score is a single question that asks patients to rate their affected shoulder as a percentage of normal to provide a simple and efficient measure of patient outcome (Gowd et al., 2019).
Patients will be asked the following question: "How would you rate your affected shoulder today as a percentage of normal (0% to 100% scale with 100% being normal)?"
|
12 Months, post-operative
|
|
SANE Score
Time Frame: 24 Months, post-operative
|
The Single Assessment Numeric Evaluation (SANE) score is a single question that asks patients to rate their affected shoulder as a percentage of normal to provide a simple and efficient measure of patient outcome (Gowd et al., 2019).
Patients will be asked the following question: "How would you rate your affected shoulder today as a percentage of normal (0% to 100% scale with 100% being normal)?"
|
24 Months, post-operative
|
|
Constant Score
Time Frame: Baseline, pre-operative
|
The Constant Score is validated and reliable PROM/clinical tool used to evaluate overall shoulder function based on pain, activities of daily living, and the clinical evaluation of ROM and strength (Constant & Murley, 1987).
This score is widely reported in European-based literature.
Minimum value is 0 and maximum value is 100, with higher scores being a better outcome.
|
Baseline, pre-operative
|
|
Constant Score
Time Frame: 3 Months, post-operative
|
The Constant Score is validated and reliable PROM/clinical tool used to evaluate overall shoulder function based on pain, activities of daily living, and the clinical evaluation of ROM and strength (Constant & Murley, 1987).
This score is widely reported in European-based literature.
Minimum value is 0 and maximum value is 100, with higher scores being a better outcome.
|
3 Months, post-operative
|
|
Constant Score
Time Frame: 6 Months, post-operative
|
The Constant Score is validated and reliable PROM/clinical tool used to evaluate overall shoulder function based on pain, activities of daily living, and the clinical evaluation of ROM and strength (Constant & Murley, 1987).
This score is widely reported in European-based literature.
Minimum value is 0 and maximum value is 100, with higher scores being a better outcome.
|
6 Months, post-operative
|
|
Constant Score
Time Frame: 12 Months, post-operative
|
The Constant Score is validated and reliable PROM/clinical tool used to evaluate overall shoulder function based on pain, activities of daily living, and the clinical evaluation of ROM and strength (Constant & Murley, 1987).
This score is widely reported in European-based literature.
Minimum value is 0 and maximum value is 100, with higher scores being a better outcome.
|
12 Months, post-operative
|
|
Constant Score
Time Frame: 24 Months, post-operative
|
The Constant Score is validated and reliable PROM/clinical tool used to evaluate overall shoulder function based on pain, activities of daily living, and the clinical evaluation of ROM and strength (Constant & Murley, 1987).
This score is widely reported in European-based literature.
Minimum value is 0 and maximum value is 100, with higher scores being a better outcome.
|
24 Months, post-operative
|
|
Range of Motion
Time Frame: Baseline, pre-operative
|
For both shoulders, forward flexion and external rotation at 0 and 90 degrees abduction will be measured with a goniometer and reported in degrees.
|
Baseline, pre-operative
|
|
Range of Motion
Time Frame: 3 Months, post-oeprative
|
For both shoulders, forward flexion and external rotation at 0 and 90 degrees abduction will be measured with a goniometer and reported in degrees.
|
3 Months, post-oeprative
|
|
Range of Motion
Time Frame: 6 Months, post-operative
|
For both shoulders, forward flexion and external rotation at 0 and 90 degrees abduction will be measured with a goniometer and reported in degrees.
|
6 Months, post-operative
|
|
Range of Motion
Time Frame: 12 Months, post-operative
|
For both shoulders, forward flexion and external rotation at 0 and 90 degrees abduction will be measured with a goniometer and reported in degrees.
|
12 Months, post-operative
|
|
Range of Motion
Time Frame: 24 Months, post-oeprative
|
For both shoulders, forward flexion and external rotation at 0 and 90 degrees abduction will be measured with a goniometer and reported in degrees.
|
24 Months, post-oeprative
|
|
Isometric Strength
Time Frame: Baseline, pre-operative
|
Measured using a hand-held dynamometer, in flexion, abduction, and external rotation.
|
Baseline, pre-operative
|
|
Isometric Strength
Time Frame: 3 Months, post-operative
|
Measured using a hand-held dynamometer, in flexion, abduction, and external rotation.
|
3 Months, post-operative
|
|
Isometric Strength
Time Frame: 6 Months, post-operative
|
Measured using a hand-held dynamometer, in flexion, abduction, and external rotation.
|
6 Months, post-operative
|
|
Isometric Strength
Time Frame: 12 Months, post-operative
|
Measured using a hand-held dynamometer, in flexion, abduction, and external rotation.
|
12 Months, post-operative
|
|
Isometric Strength
Time Frame: 24 Months, post-operative
|
Measured using a hand-held dynamometer, in flexion, abduction, and external rotation.
|
24 Months, post-operative
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Jarret Woodmass, MD, Pan Am Clinic
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
August 1, 2024
Primary Completion (Estimated)
October 1, 2026
Study Completion (Estimated)
October 1, 2027
Study Registration Dates
First Submitted
February 1, 2023
First Submitted That Met QC Criteria
March 27, 2023
First Posted (Actual)
March 28, 2023
Study Record Updates
Last Update Posted (Actual)
April 2, 2024
Last Update Submitted That Met QC Criteria
April 1, 2024
Last Verified
April 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- RCBAL-01-2023
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.